Pharma Outsourcing Needs Are Boosting Contract Manufacturer Markets

March 19, 2018

WELLESLEY, Mass., March 19, 2018 – Contract manufacturing, also called “outsourcing,” has become an inevitable part of drug manufacturing, and the market is growing steadily. In a new report Global Markets for Contract Pharmaceutical Manufacturing, Research and Packaging, BCC Research estimates this market will reach $136.4 billion and $197.0 billion in 2017 and 2022, respectively, indicating a compound annual growth rate (CAGR) of 7.6%.

Contract manufacturing establishes a working agreement between two companies. As part of the agreement, one company custom produces goods on behalf of its client. Through outsourcing, the client does not have to maintain manufacturing facilities or purchase raw materials to produce the finished goods.

Pharmaceutical companies price-squeezed by healthcare providers and governments – along with the patent cliff – have approached contract manufacturing organizations to maintain their positions in a highly competitive environment. The peak of the patent cliff has passed, and research and development productivity is growing in the industry. Outsourcing that has been transformed from “pay for services” to “partnerships and collaborations” is considered the most successful strategy to bring innovation into the drug industry.

Research Highlights

  • The global contract research market, which totaled $48.1 billion in 2016, is expected to achieve a 9.8% CAGR from 2017-2022.
  • The market for contract manufacture of bulk and dosage form drugs will grow from $74.8 billion in 2017 to $100.9 billion by 2022 with a CAGR of 6.2%.
  • The growing demand for innovative, sustainable, and eco-friendly packaging and serialization should spur healthy a growth rate (6.1% CAGR) in the contract packaging market.

“Continued advancements in the bio/pharmaceuticals, including unit dose vials, anti-counterfeit measures, two-in-one prefilled vials, senior-friendly packaging and child-resistant packs, are driving growth in the contract packaging market,” said Shalini S. Dewan, BCC Research analyst and author of the report. “Bio/pharmaceutical companies must invest millions of dollars in non-core packaging activities to keep pace with market demands, so they started outsourcing to meet their packaging requirements. In the contract research market, outsourcing reduces development costs, as opposed to making investments for every part of drug discovery and development.”

Editors/reporters requesting analyst interviews should contact 

Qualified members of the press can also request permission to access the BCC Research library.

Global Markets for Contract Pharmaceutical Manufacturing, Research and Packaging( PHM043G )
Publish Date: Mar 2018    

Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email or visit to request access to our library of market research.